The pharmacodynamic equivalence of Orlistat 60 mg capsule. An open label, balanced, randomized, multiple-dose, cross-over pharmacodynamic end-point bioequivalence study in healthy, adult, human Asian Indian subjects under fed conditions

Author： Kumar Sudershan   Monif Tausif   Arora Rachna   Khuroo Arshad   Jain Rakesh   Reyar Simrit   Verma Priya Ranjan Prasad   Rao Shireen  

Publisher： Informa Healthcare

ISSN： 1060-1333

Source： Clinical Research and Regulatory Affairs, Vol.30, Iss.4, 2013-12, pp. : 55-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bioequivalence of Sitagliptin/Metformin Fixed-Dose Combination Tablets and Concomitant Administration of Sitagliptin and Metformin in Healthy Adult Subjects: A Randomized, Open-Label, Crossover Study

By Migoya Elizabeth M.  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 855-866

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Orally Administered Single- and Multiple-Dose Olopatadine in Healthy Chinese Subjects: An Open-Label Study

By Chu Nan-Nan   Chen Wei-Li   Xu Hong-Rong   Li Xue-Ning  

Clinical Drug Investigation, Vol. 29, Iss. 7, 2009-06 ,pp. : 451-457

Adis International

Access to resources Recommend Favorite

Dose Proportionality of Fentanyl Buccal Tablet in Doses Ranging from 600 to 1300 μg in Healthy Adult Subjects: A Randomized, Open-Label, Four-Period, Crossover, Single-Centre Study

By Darwish Mona  

Clinical Drug Investigation, Vol. 30, Iss. 6, 2010-06 ,pp. : 365-373

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of two formulations of alendronate sodium/cholecalciferol (vitamin D3) tablets 70 mg/5600 IU: An open-label, randomized, single-dose, two-treatment, two-period, two-sequence, cross-over, bioequivalence study

By Tippabhotla Sudhakar Koundinya   Thota Satyanarayana   Khan Sohel Md.   Gadiko Chaitanya   Yergude Sandeep   Cheerla Raju   Nakkawar Mukesh   Betha Madhava Rao   Battula Ramakrishna   Vobalaboina Venkateswarlu  

Clinical Research and Regulatory Affairs, Vol. 30, Iss. 1-2, 2013-03 ,pp. : 14-22

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic-Pharmacodynamic Interaction between Nebicapone, a Novel Catechol-O-Methyltransferase Inhibitor, and Controlled-Release Levodopa/Carbidopa 200 mg/50 mg: Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects

By Vaz-da-Silva Manuel  

Drugs in R&D, Vol. 9, Iss. 6, 2008-01 ,pp. : 435-446

Adis International

Access to resources Recommend Favorite